Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 22, 2025 | $1.69 | 2025-08-25 | 2025-08-19 |
Dividends Summary
- Consistent Payer: has rewarded shareholders with 1 dividend payments over the past 0 years.
- Total Returned Value: Investors who held EPIX shares during this period received a total of $1.69 per share in dividend income.
- Latest Payout: The most recent dividend of $1.69/share was paid 154 days ago, on August 22, 2025.
Company News
ESSA Pharma Inc. announced a $80 million return of capital distribution to shareholders as part of its discontinuance and winding-up transaction with XenoTherapeutics, with distribution scheduled for August 22, 2025.
Law firm Monteverde & Associates is investigating the proposed sale of ESSA Pharma to Xeno Acquisition Corp, examining the fairness of the transaction terms for shareholders.
ESSA Pharma announced the termination of its Phase 2 trial for a prostate cancer treatment, citing lack of efficacy and futility. This led to a significant drop in the company's stock price.
A class action lawsuit has been filed against ESSA Pharma Inc. (EPIX) alleging the company made materially false and misleading statements about the efficacy of its drug masofaniten in combination with enzalutamide for treating prostate cancer.
ESSA Pharma announced the termination of its Phase 2 trial for a prostate cancer treatment, citing lack of efficacy and futility. The company's stock price fell significantly on this news.
